tradingkey.logo
搜尋

Advanced Biomed Inc

ADVB
添加自選
10.875USD
-3.485-24.27%
收盤 07-28 16:00美東報價延遲15分鐘
15.03M總市值
0.21本益比TTM

關於 Advanced Biomed Inc 公司

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc簡介

公司代碼ADVB
公司名稱Advanced Biomed Inc
上市日期Mar 06, 2025
CEO- -
員工數量31
證券類型Ordinary Share
年結日Mar 06
公司地址401 Ryland St
城市RENO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編89502
電話1862120510823
網址http://www.advanbiomed.com/
公司代碼ADVB
上市日期Mar 06, 2025
CEO- -

Advanced Biomed Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

常見問題

Advanced Biomed Inc的前五大股東是誰?

Advanced Biomed Inc的前五大股東如下:Dr. I-Fang (Steven) Cheng, Ph.D.

有多少機構持有Advanced Biomed Inc(ADVB)的股份?

截至2026Q1,共有6家機構持有Advanced Biomed Inc的股份,合計持有的股份價值約為1.99K,占公司總股份的0.12% 。與2025Q4相比,機構持股有所增加,增幅為-12429.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有